BeOne Medicines
ONC
#603
Rank
โ‚ฌ37.13 B
Marketcap
328,23ย โ‚ฌ
Share price
2.10%
Change (1 day)
15.74%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: โ‚ฌ37.13 Billion

As of September 2026 BeOne Medicines has a market cap of โ‚ฌ37.13 Billion. This makes BeOne Medicines the world's 603th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ37.13 B26.18%
2025โ‚ฌ29.42 B49.52%
2024โ‚ฌ19.68 B10.36%
2023โ‚ฌ17.83 B-24.79%
2022โ‚ฌ23.70 B-3.38%
2021โ‚ฌ24.53 B27.53%
2020โ‚ฌ19.24 B110.98%
2019โ‚ฌ9.12 B24.85%
2018โ‚ฌ7.30 B96.96%
2017โ‚ฌ3.70 B223.87%
2016โ‚ฌ1.14 B

End of Day market cap according to different sources

On Sep 29th, 2026 the market cap of BeOne Medicines was reported to be:

โ‚ฌ36.55 Billion
by Nasdaq info icon info icon
โ‚ฌ36.36 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
โ‚ฌ1.06 B-97.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ18.39 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA